Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab
Clinical trial NCT05346861 · UNKNOWN
Trial details
- NCT number
- NCT05346861
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2023-10-31
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.